Iowa City, IA, United States of America

Michael B Cohen


Average Co-Inventor Count = 3.0

ph-index = 2

Forward Citations = 19(Granted Patents)


Company Filing History:


Years Active: 2001-2003

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Michael B Cohen: Innovator in Cancer Diagnostics

Introduction

Michael B Cohen is a prominent inventor based in Iowa City, IA (US). He has made significant contributions to the field of cancer diagnostics, holding a total of 3 patents. His work focuses on developing innovative methods and antibodies that aid in the detection and evaluation of cancerous tissues.

Latest Patents

One of his latest patents involves the development of prostate cell surface antigen-specific antibodies. This invention discloses an antibody that binds to a protein found on both normal and cancerous prostate cells, while being absent on nonprostate cells. Additionally, it includes a hybridoma that produces this antibody, along with antibodies conjugated to labels or cytotoxic moieties. Another significant patent pertains to the evaluation of adenocarcinoma of the prostate and breast using anti-dystroglycan antibodies. This method provides a way to diagnose the tumorigenic grade of malignant tissue by determining the amount of dystroglycan protein relative to a standard. The patent outlines various methods for measuring dystroglycan levels, including mRNA transcript analysis and western blot analysis. This method is particularly applicable to human malignant tissues, especially adenocarcinoma of the prostate or mammary adenocarcinoma.

Career Highlights

Michael B Cohen is affiliated with the University of Iowa Research Foundation, where he continues to advance his research in cancer diagnostics. His innovative approaches have the potential to significantly impact the early detection and treatment of cancer.

Collaborations

He has collaborated with notable colleagues such as George J Weiner and Oskar W Rokhlin, contributing to the advancement of cancer research and diagnostics.

Conclusion

Michael B Cohen's work exemplifies the intersection of innovation and healthcare, particularly in the realm of cancer diagnostics. His patents reflect a commitment to improving patient outcomes through advanced diagnostic methods.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…